Atrial Fibrillation and Cancer: Understanding Their Connection
Author Information
Author(s): Davis Nathaniel E., Prasitlumkum Narut, Tan Nicholas Y.
Primary Institution: Mayo Clinic
Hypothesis
The review investigates the relationship between atrial fibrillation (AF) and cancer, exploring their epidemiology, mechanisms, and management challenges.
Conclusion
The study highlights the complex interplay between atrial fibrillation and cancer, emphasizing the need for further research and a multidisciplinary approach to management.
Supporting Evidence
- Cancer patients show elevated incidences of atrial fibrillation, particularly with advanced disease.
- AF may precede cancer diagnoses in some patients, suggesting a bidirectional relationship.
- Management of AF in cancer patients is complicated by drug interactions and limited data on treatment efficacy.
Takeaway
Atrial fibrillation and cancer are linked, with cancer patients often experiencing higher rates of AF, and managing both conditions together can be tricky.
Methodology
This is a comprehensive review that synthesizes existing literature on the epidemiology, mechanisms, and management of atrial fibrillation in cancer patients.
Potential Biases
Potential biases include differences in reporting based on race and the lack of sex-stratified analysis.
Limitations
The review acknowledges the variability in reported AF rates among cancer patients and the need for more standardized research methodologies.
Participant Demographics
The review discusses various cancer types, particularly lung, colorectal, gastrointestinal, and hematologic malignancies, but does not provide specific demographic data.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website